InVivo Therapeutics Corp... (NVIV)
NASDAQ: NVIV
· Real-Time Price · USD
0.32
-0.17 (-34.43%)
At close: Feb 12, 2024, 9:00 PM
InVivo Therapeutics Revenue
InVivo Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending September 30, 2023, InVivo Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
6
Market Cap
995.92K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|